(Q44123167)

30 November 2017

title

Clinical and economic outcomes of conventional amphotericin B-associated nephrotoxicity (English)

1 reference

30 November 2017

1

Stephan Harbarth

1 reference

30 November 2017

6

Matthew H Samore

1 reference

30 November 2017

John P Burke

2

1 reference

30 November 2017

James F Lloyd

series ordinal

3

1 reference

30 November 2017

R Scott Evans

series ordinal

4

1 reference

30 November 2017

Stanley L Pestotnik

series ordinal

5

1 reference

30 November 2017

language of work or name

English

0 references

publication date

2 December 2002

1 reference

Clinical Infectious Diseases

30 November 2017

published in

1 reference

30 November 2017

volume

35

1 reference

30 November 2017

issue

12

1 reference

30 November 2017

page(s)

e120-7

1 reference

Incidence of lethal adverse drug reactions in the comprehensive hospital drug monitoring, a 20-year survey, 1974-1993, based on the data of Berne/St. Gallen

30 November 2017

cites work

1 reference

Clinical significance of nephrotoxicity in patients treated with amphotericin B for suspected or proven aspergillosis

21 January 2018

1 reference

Mortality and costs of acute renal failure associated with amphotericin B therapy

21 January 2018

1 reference

The epidemiology of nephrotoxicity associated with conventional amphotericin B therapy

21 January 2018

1 reference

Risk factors for amphotericin B-induced nephrotoxicity

21 January 2018

1 reference

Time-dependent covariates in the Cox proportional-hazards regression model

21 January 2018

1 reference

Diagnostic plots to reveal functional form for covariates in multiplicative intensity models.

21 January 2018

1 reference

A method for checking regression models in survival analysis based on the risk score.

21 January 2018

1 reference

Comparison of analytic models for estimating the effect of clinical factors on the cost of coronary artery bypass graft surgery

21 January 2018

1 reference

Methods for analyzing health care utilization and costs

21 January 2018

1 reference

Estimating the effect of cardiovascular risk factors on all-cause mortality and incidence of coronary heart disease using G-estimation: the atherosclerosis risk in communities study

21 January 2018

1 reference

Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine

21 January 2018

1 reference

Estimating medical costs from incomplete follow-up data

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/344468

1 reference

30 November 2017

1 reference